Ion-pair reversed-phase HPLC: assay validation of sodium tanshinone IIA sulfonate in mouse plasma

J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Feb 2;831(1-2):163-8. doi: 10.1016/j.jchromb.2005.11.045. Epub 2006 Jan 10.

Abstract

Sodium tanshinone IIA sulfonate (STS), a hydrophilic ionic substance, is used as a cardiovascular drug. An ion-pair reversed-phase high-performance liquid chromatography (IP-RP-HPLC) method for the determination of STS in mouse plasma was initially developed. The assay involved a rapid and simple extraction process and subsequent detection at 271 nm. The retention time for STS was 7.5 min. Based on extracted STS standard mouse plasma at 1.5,10 and 50 microg/ml, the assay precision were 2.7, 2.1 and 1.7% with a mean accuracy of 96.7, 98.5 and 99.4%, respectively. At plasma concentration of 1.5, 50 and 75 microg/ml, the mean recovery of STS were 93.1, 96.3 and 97.5%. The limit of detection (LOD) and limit of quantification (LOQ) for STS was 0.1 microg/ml and 0.5 microg/ml, respectively. Linear responses were observed over a wide concentration range (0.5-100 microg/ml) for STS in mouse plasma. STS can be detected after intravenous administration. This method was performed for the first time in pharmacokinetic studies of STS in the mouse.

Publication types

  • Validation Study

MeSH terms

  • Animals
  • Chromatography, High Pressure Liquid / methods*
  • Drug Stability
  • Male
  • Mice
  • Phenanthrenes / blood*
  • Phenanthrenes / pharmacokinetics
  • Quaternary Ammonium Compounds / chemistry
  • Reproducibility of Results
  • Spectrophotometry, Ultraviolet

Substances

  • Phenanthrenes
  • Quaternary Ammonium Compounds
  • tanshinone II A sodium sulfonate
  • tetrabutylammonium